c-Jun NH(2)-terminal kinase 2alpha2 promotes the tumorigenicity of human glioblastoma cells.

c-Jun NH(2)-terminal kinase 2alpha2 promotes the tumorigenicity of human glioblastoma cells. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

c-Jun NH(2)-terminal kinase 2alpha2 promotes the tumorigenicity of human glioblastoma cells. Abstract Text:

Jian Cui,Shuang-Yin Han,Congli Wang,Wanwen Su,Larry Harshyne,Marina Holgado-Madruga,Albert J Wong,

c-Jun NH(2)-terminal kinases (JNK) are members of the mitogen-activated protein kinase family and have been implicated in the formation of several human tumors, especially gliomas. We have previously shown that a 55 kDa JNK isoform is constitutively active in 86% of human brain tumors and then showed that it is specifically a JNK2 isoform and likely to be either JNK2alpha2 or JNK2beta2. Notably, we found that only JNK2 isoforms possess intrinsic autophosphorylation activity and that JNK2alpha2 has the strongest activity. In the present study, we have further explored the contribution of JNK2 isoforms to brain tumor formation. Analysis of mRNA expression by reverse transcription-PCR revealed that JNK2alpha2 is expressed in 91% (10 of 11) of glioblastoma tumors, whereas JNK2beta2 is found in only 27% (3 of 11) of tumors. Both JNK2alpha2 and JNK2beta2 mRNAs are expressed in normal brain (3 of 3). Using an antibody specific for JNK2alpha isoforms, we verified that JNK2alpha2 protein is expressed in 88.2% (15 of 17) of glioblastomas, but, interestingly, no JNK2alpha2 protein was found in six normal brain samples. To evaluate biological function, we transfected U87MG cells with green fluorescent protein-tagged versions of JNK1alpha1, JNK2alpha2, and JNK2alpha2APF (a dominant-negative mutant), and derived cell lines with stable expression. Each cell line was evaluated for various tumorigenic variables including cellular growth, soft agar colony formation, and tumor formation in athymic nude mice. In each assay, JNK2alpha2 was found to be the most effective in promoting that phenotype. To identify effectors specifically affected by JNK2alpha2, we analyzed gene expression. Gene profiling showed several genes whose expression was specifically up-regulated by JNK2alpha2 but down-regulated by JNK2alpha2APF, among which eukaryotic translation initiation factor 4E (eIF4E) shows the greatest change. Because AKT acts on eIF4E, we also examined AKT activation. Unexpectedly, we found that JNK2alpha2 could specifically activate AKT. Our data provides evidence that JNK2alpha2 is the major active JNK isoform and is involved in the promotion of proliferation and growth of human glioblastoma tumors through specific activation of AKT and overexpression of eIF4E.

c-Jun NH(2)-terminal kinase 2alpha2 promotes the tumorigenicity of human glioblastoma cells. Publishing Authors By Initials

J Cui,SY Han,C Wang,W Su,L Harshyne,M Holgado-Madruga,AJ Wong,

For similar genetic processes: gene expression regulation: up-regulation research abstracts see: genetic processes: gene expression regulation: up-regulation research

PUBMED ID PMID:

MEDLINE DATE:

c-Jun NH(2)-terminal kinase 2alpha2 promotes the tumorigenicity of human glioblastoma cells. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: Cancer research

VOLUME: 66

Page Numbers: 10024-31

Journal Abbreviation: Cancer Res.

ISSN: 0008-5472

DAY: 15

MONTH: Oct

YEAR: 2006

c-Jun NH(2)-terminal kinase 2alpha2 promotes the tumorigenicity of human glioblastoma cells. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 2984705

c-Jun NH(2)-terminal kinase 2alpha2 promotes the tumorigenicity of human glioblastoma cells. Keywords Mesh Terms:

KEYWORDS: Up-Regulation

MESH TERMS: metabolism

Chemical & Substance for Abstract: c-Jun NH(2)-terminal kinase 2alpha2 promotes the tumorigenicity of human glioblastoma cells. Information

Substance Name: Proto-Oncogene Proteins c-akt

Registry Number: EC 2.7.1.37

Grant and Affiliation Information for c-Jun NH(2)-terminal kinase 2alpha2 promotes the tumorigenicity of human glioblastoma cells.

AFFILIATION: Department of Neurosurgery, Stanford University Medical Center, Stanford, California 94305, USA.

Country: United States

AGENCY: United States NCI

GRANT: CA96539

ACRONYM: CA

MEDLINETA: Cancer Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

c-Jun NH2-terminal kinase 2alpha2 promotes the tumorigenicity of human glioblastoma cells Related Publications

• A simple microindentation technique for mapping the microscale compliance of soft hydrated materials and tissues.
• A study of density of states and ground states in hydrophobic-hydrophilic protein folding models by equi-energy sampling.
• An extended simplified reference tissue model for the quantification of dynamic PET with amphetamine challenge.
• Cell cycle dysregulation in oral cancer.
• Characterization of a transglycosylase domain of Streptococcus pneumoniae PBP1b.
• Differentially expressed protein markers in human submandibular and sublingual secretions.
• Dose effects of triazolam on brain activity during episodic memory encoding: a PET study.
• Driver perception response time during the signal change interval.
• Expression of cell-cycle regulator CDK2-associating protein 1 (p12CDK2AP1) in transgenic mice induces testicular and ovarian atrophy in vivo.
• Extracellular heat shock protein-70 induces endotoxin tolerance in THP-1 cells.
• Feruloyl esterase: a key enzyme in biomass degradation.
• German cockroach proteases regulate matrix metalloproteinase-9 in human bronchial epithelial cells.
• HIV Evolution and Escape.
• Health services utilization for people with HIV infection: comparison of a population targeted for outreach with the U.S. population in care.
• In vivo imaging reveals dendritic targeting of laminated afferents by zebrafish retinal ganglion cells.
• In vivo optical coherence tomography of the nasal mucosa.
• Measurement of serum D-arabinitol/creatinine ratios for initial diagnosis and for predicting outcome in an unselected, population-based sample of patients with Candida fungemia.
• Mechanism and function of heat shock-dependent IkappaBalpha expression.
• Mycotic aortic aneurysm following treatment of pyogenic vertebral osteomyelitis.
• Prediction of breast cancer using volatile biomarkers in the breath.
• Prolonged and severe dysphagia following anterior cervical surgery.
• Sugar-assisted ligation of N-linked glycopeptides with broad sequence tolerance at the ligation junction.
• The executive clock drawing task (CLOX) is a poor screening test for executive dysfunction in Chinese elderly patients with subcortical ischemic vascular disease.
• The relationship between parent emotion, parent behavior, and health status of young African American and Latino children.
• [Advances of fine needle aspiration cytology]
• [Biosynthesis and characterization of jarosite]
• [Creation of the World Federation of Critical Care Nursing (WFCCN)]
• [Effect of oxygen on the fluorescence of sol-gel with ruthenium complexes]
• [In Process Citation]
• c-Jun NH(2)-terminal kinase 2alpha2 promotes the tumorigenicity of human glioblastoma cells.